Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study.
Kneepkens EL, van den Oever I, Plasencia CH, Pascual-Salcedo D, de Vries A, Hart M, Nurmohamed MT, Balsa A, Rispens T, Wolbink G. Kneepkens EL, et al. Among authors: van den oever i. Scand J Rheumatol. 2017 Mar;46(2):87-94. doi: 10.1080/03009742.2016.1183039. Epub 2016 Jul 20. Scand J Rheumatol. 2017. PMID: 27440258
Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme.
Heslinga M, Van Den Oever I, Jonker DL, Griep EN, Griep-Wentink H, Smulders YM, Lems WF, Boers M, Voskuyl AE, Peters M, Van Schaardenburg D, Nurmohamed MT. Heslinga M, et al. Among authors: van den oever i. Scand J Rheumatol. 2019 Sep;48(5):345-352. doi: 10.1080/03009742.2019.1600718. Epub 2019 Jun 18. Scand J Rheumatol. 2019. PMID: 31210083
Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project.
van den Oever IAM, Heslinga M, Griep EN, Griep-Wentink HRM, Schotsman R, Cambach W, Dijkmans BAC, Smulders YM, Lems WF, Boers M, Voskuyl AE, Peters MJL, van Schaardenburg D, Nurmohamed MT. van den Oever IAM, et al. Rheumatology (Oxford). 2017 Sep 1;56(9):1472-1478. doi: 10.1093/rheumatology/kew497. Rheumatology (Oxford). 2017. PMID: 28199724
Comparing inflammatory cell density in the myocardium and coronary arteries in rheumatoid arthritis patients versus controls with myocardial infarction: A post-mortem case-control study.
van den Oever IA, van Sijl AM, Baylan U, Ter Wee MM, Schalkwijk CG, Krijnen PA, Nurmohamed MT, Voskuyl AE, Niessen HW, Simsek S. van den Oever IA, et al. Int J Cardiol. 2016 Apr 15;209:74-6. doi: 10.1016/j.ijcard.2016.02.065. Epub 2016 Feb 3. Int J Cardiol. 2016. PMID: 26882189 Free article. No abstract available.
Niacin for reduction of cardiovascular risk.
van den Oever IA, Nurmohamed MT, Lems WF. van den Oever IA, et al. N Engl J Med. 2014 Nov 13;371(20):1942. doi: 10.1056/NEJMc1411240. N Engl J Med. 2014. PMID: 25390752 No abstract available.
12 results